Tiny calcium deposits can be a telltale sign of breast cancer. However, in the majority of cases these microcalcifications signal a benign condition. A new diagnostic procedure developed at Massachusetts Institute of Technology and Case Western Reserve University could help doctors more accurately distinguish between cancerous and noncancerous cases.
Emerging from a panel of 2,400 medications and drug-like compounds tested in a tiny zebrafish, a compound has been pinpointed by researchers who say it regulates whole-body metabolism and appears to protect obese mice from signs of metabolic disorders. The discovery may help drug discovery efforts to help help the rising population of Americans adults at risk for diabetes and other metabolic disorders.
New combinations of medical imaging technologies hold promise for improved early disease screening, cancer staging, therapeutic assessment, and other aspects of personalized medicine, according to a new Virginia Tech report. The integration of multiple major tomographic scanners into a single framework involves the fusion of many imaging modalities known as "omni-tomography”.
You can see the color white; you can hear white noise. Now, researchers have shown that you can also smell a white odor. To be perceived as white, a stimulus (like light or sound) must meet two conditions: The mix that produces them must span the range of our perception; and each component must be present at the exact same intensity. Neuroscientists have reproduced these conditions for scent.
A sensor invented by Tufts University bioengineers, when attached temporarily to a tooth, could one day help dentists fine-tune treatments for patients with chronic periodontitis, for example, or even provide a window on a patient’s overall health. The thin foil-like sensor is built from gold, silk, and graphite, has a built-in antenna to receive power and signals, and is applied directly to a tooth.
A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute enables detection of microRNA from extremely small sample volume in only 20 minutes. By drastically reducing the time and quantity of sample required for detection, the chip lays the groundwork for early-stage point-of-care diagnosis of diseases.
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it’s coming from a children’s hospital. Nationwide Children’s Hospital in Columbus, Ohio, and Transformatix Technologies, Inc., in Davis, California, have partnered to create BioLinQ, a new biomedical informatics company designed to supply advanced software solutions for disease diagnosis and medical research.
Scientists in the U.K. have built a sensor that would enable doctors to detect the early stages of diseases and viruses with the naked eye. The sensor works by analyzing serum, derived from blood. If the result is positive, a reaction that generates irregular clumps of nanoparticles gives off a distinctive blue hue in a solution inside the container. If the results are negative the nanoparticles separate into ball-like shapes, creating a reddish hue.
When someone develops liver cancer, the disease introduces a very subtle difference to their bloodstream, increasing the concentration of a particular molecule by just 10 parts per billion. That small shift is normally difficult to detect without sophisticated equipment, but new lab-on-a-chip technology designed at Brigham Young University can reveal the presence of ultra-low concentrations of a target molecule.
The claim that nanopore technology is on the verge of making DNA analysis so fast and cheap that a person's entire genome could be sequenced at low cost in just minutes has produced intense interest. But a review by Northeastern University physicist Meni Wanunu questions whether the remaining technical hurdles can be overcome to create a workable, easily produced commercial device.
Scientists at Argonne National Laboratory have developed a safe and affordable way to ensure a reliable U.S. supply of certain medical isotopes. Although the invention is at a conceptual stage, it has the potential to provide critical medical diagnostic material for small regional hospitals.
An international team of scientists has discovered a new method for coloring the cell wall of bacterial cells to determine how they grow. Multicolored probes target cell wall synthesis, labeling them with nontoxic dyes. The technique provides a new, much-needed tool for the development of new antibiotics.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, University of Pennsylvania scientists have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see. Their result could, among other things, guide efforts to restore vision using a neural prosthesis that stimulates the surface of the brain.
A University of Washington bioengineer has recently developed a way to make regular paper stick to medically interesting molecules. The work produced a chemical trick to make paper-based diagnostics using plain paper, the kind found at office supply stores around the world.
According to a team of Penn State University researchers, a technique that uses acoustic waves to sort cells on a chip may create miniature medical analytic devices that could make Star Trek's tricorder seem a bit bulky in comparison. The device uses two beams of acoustic—or sound—waves to act as acoustic tweezers and sort a continuous flow of cells on a dime-sized chip.
In the operating room, surgeons can see inside the human body in real time using advanced imaging techniques, but primary care physicians haven't commonly had access to the same technology. Engineers from the University of Illinois at Urbana-Champaign have recently created a new imaging tool for them: a handheld scanner that would enable them to image all the sites they commonly examine, such as bacterial colonies in the middle ear in 3D, or the thickness and health of patients' retinas.
It's a medical nightmare: a 24-year-old man endures 350 surgeries since childhood to remove growths that keep coming back in his throat and have spread to his lungs, threatening his life. A new discovery, however, allows doctors to grow "mini tumors" from each patient's cancer in a lab dish, then test various drugs or combinations on them to see which works best.
By mimicking nature's own sensing mechanisms, bioengineers have designed inexpensive medical diagnostic tests that take only a few minutes to perform. The rapid and easy-to-use diagnostic test consists of a nanometer-scale DNA "switch" that can quickly detect antibodies specific to a wide range of diseases.
As part of his doctoral research at the California Institute of Technology, Sebastian Maerkl designed a device that he named “MITOMI”—a small device containing hundreds of microfluidic channels equipped with pneumatic valves. Now with EPFL’s Bioengineering Institute in Switzerland, Maerkl has developed the new k-MITOMI, which is smaller than a domino but can simultaneously measure hundreds of biomolecular interactions.
If you throw a ball underwater, you'll find that the smaller it is, the faster it moves: A larger cross-section greatly increases the water's resistance. Now, a team of researchers has figured out a way to use this basic principle, on a microscopic scale, to carry out biomedical tests that could eventually lead to fast, compact, and versatile medical testing devices.
Reactive oxygen species (ROS), such as hydrogen peroxide, are produced by a chemical balance disturbance, such as inflammation, within a tissue. Because these ROS are indicators of many diseases, a non-invasive detection method would be very useful. Researchers at the University of California, San Diego have developed the first degradable polymer that is extremely sensitive to low but biologically relevant concentrations of hydrogen peroxide.
In a pre-clinical non-small-cell lung cancer metastasis model in mice, a research team at the University of Massachusetts, Amherst uses a sensor array system of gold nanoparticles and proteins to “smell” different cancer types in much the same way our noses identify and remember different odors.
Troponin I, found exclusively in heart muscle, is already used as the gold-standard marker in blood tests to diagnose heart attacks, but the new findings by Johns Hopkins University researchers reveal why and how the same protein is also altered in heart muscle malfunctions that lead to heart failure. Scientists have known of “out-of-tune” proteins for a while, but the precise origin had remained unclear.
An interdisciplinary team of nine Arizona State University students participating in the 2012 International Genetically Engineered Machine (iGEM) competition have embarked on a campaign to help reduce the 1.5 million global deaths of children each year caused by diarrheal disease. The goal is an inexpensive biosensor that detects contaminated water quickly. But the challenge is which biosensor design to pursue.